Important notice

Meds75+ – information regarding the use for persons aged 75+

Substances A-Z
  • Ca

  • Calcii carbonas
    Class A
    Suitable for older persons.
    Class A
    Suitable for older persons. Absorption weakens as stomach acidity decreases. Take the interactions in the absorption phase into account.
  • Calcipotriolum
  • Calcitriolum
  • Candesartanum cilexetilum
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in even mild renal insufficiency. Monitor renal function during the pharmacotherapy. Avoid concurrent use of anti-inflammatory analgesics.
  • Carbamazepinum
    Used as "ANTIEPILEPTICS"
    Class C
    Suitable for older persons, with specific cautions. Hyponatraemia is common adverse effect. Several other adverse effects, such as changes in blood count and risk of hepatic injury. Need for a Vitamin D supplement must be taken into account in long-term use. Take several and significant interactions into account before starting and discontinuing the use. Avoid consuming grapefruit during treatment.
  • Carbidopum
    Class A
    Suitable for older persons. Start therapy under specialist supervision. Absorption increases with age. Take interactions into account, especially with antipsychotics. Discontinue treatment gradually.
  • Carbidopum monohydricum
    Class A
    Suitable for older persons. Start therapy under specialist supervision. Absorption increases with age. Take interactions into account, especially with antipsychotics. Discontinue treatment gradually.
  • Carvedilolum
    Class A
    Suitable for older persons. Reduce the dose in severe renal insufficiency. Significant adverse effects include bradycardia and orthostatic hypotension. Take interactions into account, especially with drugs affecting the conduction pathways of the heart.
  • Ce

  • Celecoxibum
    Class C
    Suitable for older persons, with specific cautions. For short-term use only. May decrease renal function. Avoid use in severe renal insufficiency. May increase blood pressure, worsen cardiac insuffiency and cause cardiovascular events. Increases risk of gastrointestinal bleeding less than nonselective anti-inflammatory analgesics. Take interactions into account, especially with anticoagulants. Remember that anti-inflammatory analgesics are commonly used in self-care.
  • Cetirizini dihydrochloridum
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose and/or increase the dosing interval in even moderate renal insufficiency. May cause fatigue.
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose and/or increase the dosing interval in even moderate renal insufficiency. May cause fatigue.
  • Ch

  • Chloramphenicolum
    Class A
    Suitable for older persons. For temporary use.
  • Chlordiazepoxidum
  • Chlorhexidini digluconas
  • Ci

  • Ciclesonidum
    Class A
    Suitable for older persons. Take into account possible systemic adverse effects. Take interactions into account.
  • Cinchocaini hydrochloridum
  • Ciprofloxacinum
    Class D
    Avoid use in older persons. Risk of QT prolongation. Reduce the dose and/or increase the dosing interval in even moderate renal insufficiency. Increases the risk of tendinitis and aortic injury and valvular heart disease. Take significant interactions in the absorption phase into account, especially with iron, magnesium, aluminium, calcium and zinc. Take into account central nervous system adverse effects, especially lowered convulsive treshold and confusion.
  • Cl

  • Clarithromycinum
    Class D
    Avoid using in older persons. Reduce the dose in renal or hepatic insufficiency. Risk of QT prolongation. Take significant interactions into account.
  • Clioquinolum
  • Clomipramini hydrochloridum
    Class D
    Avoid use in older persons. Anticholinergic. Sedative. Serotonergic. Significant adverse effects include confusion, cognitive disorder, tremor, tachycardia, orthostatic hypotension and serotonin syndrome. Increases risk for falls. Take several interactions into account. Weakens the efficacy of anti-Alzheimer´s drugs.
  • Clonazepamum
    Used as "ANTIEPILEPTICS"
    Class D
    Avoid use in older persons. Sedative. A long-acting. Significant adverse effects include drug addiction, cognitive disorder and risk for traffic accidents. Increases risk for falls. Paradoxically, may increase anxiety, restlessness and aggression.
  • Clopidogrelum
    Class C
    Suitable for older persons, with specific cautions. Prodrug. Genotype affects the activation. A significant adverse effect is increased risk of bleeding. Take interactions into account. Grapefruit reduces the response.
  • Clotrimazolum
    Class A
    Topical treatment: Suitable for older persons.
    Class A
    Suitable for older persons.
  • Clozapinum
    Used as "PSYCHOLEPTICS"
    Class D
    Avoid use in older persons. Anticholinergic. Sedative. For treatment of psychosis only. Use according to the authoritative safety guidelines. Take into account especially the follow-up of blood count. Significant adverse effects include cognitive disorder, confusion, extrapyramidal symptoms, orthostatic hypotension and risk of cardiovascular events. Increases risk for falls. Smoking reduces the effect of the drug. Take several interactions into account. Weakens the efficacy of anti-Alzheimer´s drugs.
  • Co

  • Codeini phosphas hemihydricus
    Used as "ANALGESICS"
    Class D
    Avoid use in older persons. Opioid. Sedative. Prodrug. Genotype affects the response. Significant adverse effects include constipation, nausea, urinary difficulties and gallbladder problems. Increases risk of falling. Take interactions into account.
    Class D
    Avoid use in older persons. Opioid. Sedative. Prodrug. Genotype affects the response. Significant adverse effects include constipation, nausea, urinary difficulties and gallbladder problems. Increases risk of falling. Take interactions into account.
  • Coffeinum
    Used as "ANALGESICS"
    Class A
    Suitable for older persons.
  • Cy

  • Cyanocobalaminum
    Used as "VITAMINS"
    Class A
    Suitable for older persons. In vitamin B12 deficiendy, response must be determined.
    Class A
    Suitable for older persons.

Icon explanation

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Mar 30, 2021.